Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Avacta Group stock

AVCT.L
GB00BYYW9G87
A2ADP0

Price

0.50
Today +/-
+0.03
Today %
+4.60 %

Avacta Group stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Avacta Group stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Avacta Group stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Avacta Group stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Avacta Group's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Avacta Group Stock Price History

DateAvacta Group Price
12/31/20240.50 undefined
12/30/20240.48 undefined
12/27/20240.49 undefined
12/24/20240.50 undefined
12/23/20240.48 undefined
12/20/20240.48 undefined
12/19/20240.48 undefined
12/18/20240.48 undefined
12/17/20240.45 undefined
12/16/20240.46 undefined
12/13/20240.43 undefined
12/12/20240.43 undefined
12/11/20240.46 undefined
12/10/20240.44 undefined
12/9/20240.45 undefined
12/6/20240.46 undefined
12/5/20240.47 undefined
12/4/20240.47 undefined
12/3/20240.48 undefined

Avacta Group Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Avacta Group, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Avacta Group from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Avacta Group’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Avacta Group. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Avacta Group’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Avacta Group’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Avacta Group’s growth potential.

Avacta Group Revenue, EBIT and net profit per share

DateAvacta Group RevenueAvacta Group EBITAvacta Group Net Income
2026e32.72 M undefined-29.44 M undefined-29.17 M undefined
2025e27.76 M undefined-32.83 M undefined-35.28 M undefined
2024e24.88 M undefined-33.67 M undefined-36.78 M undefined
202323.25 M undefined-26.72 M undefined-24.95 M undefined
20229.65 M undefined-25.53 M undefined-36.63 M undefined
20212.94 M undefined-29.08 M undefined-26.32 M undefined
20202.14 M undefined-18.6 M undefined-18.89 M undefined
20195.51 M undefined-18.03 M undefined-15.62 M undefined
20184.12 M undefined-11.18 M undefined-9.68 M undefined
20172.76 M undefined-10.43 M undefined-8.83 M undefined
20162.74 M undefined-7.98 M undefined-6.37 M undefined
20152.17 M undefined-5.66 M undefined-4.65 M undefined
20141.81 M undefined-3.16 M undefined-9.99 M undefined
20133.18 M undefined-1.84 M undefined-1.49 M undefined
20122.7 M undefined-1.87 M undefined-1.52 M undefined
20113.13 M undefined-1.64 M undefined-1.11 M undefined
20102.45 M undefined-1.13 M undefined-590,000 undefined
20092.07 M undefined-1.66 M undefined-1.88 M undefined
2008940,000 undefined-1.95 M undefined-2.69 M undefined
2007470,000 undefined-1.65 M undefined-1.47 M undefined
2006210,000 undefined-1.36 M undefined-1.39 M undefined
20050 undefined-140,000 undefined-110,000 undefined
2004310,000 undefined-260,000 undefined-1.1 M undefined

Avacta Group Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024e2025e2026e
0000000002232312224522923242732
-----------50.00-33.3350.00-66.67100.00--100.0025.00-60.00-350.00155.564.3512.5018.52
---------550.00550.0033.3350.0066.67100.0050.0050.0050.0075.0080.0050.00550.0077.7847.8345.8340.7434.38
0000000000011211113410711000
0000-10-1-1-2-10-1-1-1-9-4-6-8-9-15-18-26-36-24-36-35-29
--------100.00-50.00----800.00-55.5650.0033.3312.5066.6720.0044.4438.46-33.3350.00-2.78-17.14
0.150.150.150.140.180.196.928.019.4912.6115.482531.5741.8249.7367.7468.4165.46110.48120.38225.65249.56255.37272.68000
---------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Avacta Group Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Avacta Group is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (k)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
200020012002200320042005200620062007200820092010201120122013201420152016201720182019202020212022
                                               
0.010.010.0200.430.170.032.532.531.10.881.431.774.190.5811.487.3319.5213.175.228.7947.9126.1941.78
0.010.01000.010.0200.060.060.050.180.560.430.320.630.470.210.160.250.30.691.571.32.47
000000.0200.080.080.090.1600.020.60.390.591.191.761.381.6732.483.317.86
00000.010000000.170.340.460.380.470.330.270.160.190.160.250.191.68
000.010.020.070.0100.030.030.040.180.250.160.190.260.360.430.630.850.810.891.043.751.76
0.020.020.030.020.520.220.032.72.71.281.42.412.725.762.2413.379.4922.3415.88.213.5353.2534.7455.55
0.190.190.150.140.22000.150.150.290.280.250.320.640.841.41.553.743.453.053.084.794.347.8
000000000000000000000002.98
0000000000000000000002.483.317.86
0000.030.6500000.040.391.322.063.324.996.695.716.837.648.377.977.16.3926.32
00000003.393.393.556.997.247.248.779.69.64.664.664.663.833.832.321.5414.23
000000000000000000000000
0.190.190.150.170.87003.543.543.887.668.819.6212.7315.4317.6911.9215.2215.7515.2614.8816.6915.5859.19
0.210.210.180.191.390.220.036.246.245.169.0611.2212.3418.4917.6731.0621.4137.5531.5523.4528.4169.9450.31114.74
                                               
0.090.090.090.50.090.090.10.860.860.91.231.511.743.233.235.055.066.926.926.9817.6725.3425.4726.61
00001.241.331.434.884.886.5211.4114.6516.4122.9922.9935.7535.760.620.630.779.8854.1454.5362.18
-0.45-0.45-0.62-0.73-0.3-1.4-1.510.280.28-2.56-4.34-6.2-6.72-7.68-9.08-10.37-20.0930.9724.9916.471.19-14.59-38.78-66
0000000000000-1.59-1.59-1.59-1.59-2.65-2.65-2.8-2.93-2.960-1.6
000000000000000000000000
-0.36-0.36-0.53-0.231.030.020.026.026.024.868.39.9611.4316.9515.5528.8419.1435.8629.8921.4125.8161.9341.2221.19
0.010.010.020.060.030.0400.080.080.130.30.410.280.770.770.980.660.40.650.830.70.860.562.49
0.010.010.030.030.030.030.020.090.090.10.290.530.360.670.480.420.740.950.681.210.982.053.053.77
00000000000.090.020.050.10.380.350.40.320.3400.10.580.472.17
0.550.550.670.330.230.10000000000000000018.73
00000.030.0300.010.010.010.010.01000000000.180.290.2940.46
0.570.570.720.420.320.20.020.180.180.240.690.970.691.541.631.751.81.671.662.041.963.784.3767.62
00000.03000.040.040.030.020.01000000000.651.751.413.75
00000000000.060.030.0100000000002.84
0000000000025020004704704702500000-18,730
00000.03000.040.040.030.080.290.2100.470.470.470.03000.651.751.41-12.14
0.570.570.720.420.350.20.020.220.220.270.771.260.91.542.12.222.271.71.662.042.65.535.7855.48
0.210.210.190.191.380.220.046.246.245.139.0711.2212.3318.4917.6531.0621.4137.5531.5523.4528.4167.464776.67
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Avacta Group provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Avacta Group's financial health and stability.

Assets

Avacta Group's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Avacta Group must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Avacta Group after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Avacta Group's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
20002001200220032004200520062006200720082009201020112012201320142015201620172018null2019202020212022
0000000-1-1-2-10-1-1-1-9-4-6-8-9-9-15-18-26-39
0000000000000002112223223
0000000000000000000000220
0000000000000000011110313
0000000000000004-1-1-1-1-1-22216
0000000000000000000000000
00000000000000000-1-1-1-1-1-2-20
0000000-1-1-2-100-10-2-4-4-5-7-7-13-10-20-16
0000000000-1-1-1-2-2-3-4-2-2-2-2-2-1-10
0000000-202-1-1-1-2-2-1-1431-2-2-2-2118-25
0000000-202000002-1064000-2020-24
0000000000000000000000000
00000000000000000000000051
0001000300314014021001010195409
00000003003140140210010101951056
-----------------------2.00--4.00
0000000000000000000000000
00000000-10002-310-420-311319-115
-0.14-0.11-0.05-0.49-0.09-0.140-1.33-1.35-2.86-2.84-1.66-2.5-3.61-3.64-6.38-8.86-6.37-7.99-9.630-15.54-12.31-21.82-17.19
0000000000000000000000000

Avacta Group stock margins

The Avacta Group margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Avacta Group. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Avacta Group.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Avacta Group's sales revenue. A higher gross margin percentage indicates that the Avacta Group retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Avacta Group's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Avacta Group's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Avacta Group's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Avacta Group. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Avacta Group's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Avacta Group Margin History

Avacta Group Gross marginAvacta Group Profit marginAvacta Group EBIT marginAvacta Group Profit margin
2026e48.37 %-89.97 %-89.14 %
2025e48.37 %-118.3 %-127.12 %
2024e48.37 %-135.31 %-147.79 %
202348.37 %-114.93 %-107.31 %
202275.03 %-264.51 %-379.49 %
2021-4.28 %-988.88 %-894.8 %
202055.13 %-867.4 %-881.11 %
201973.87 %-327.15 %-283.34 %
201878.16 %-271.36 %-234.95 %
201767.68 %-377.52 %-319.54 %
201665.59 %-291.81 %-232.8 %
201558.66 %-261.62 %-214.64 %
201470.99 %-174.3 %-551.08 %
201364.15 %-57.86 %-46.86 %
201255.93 %-69.26 %-56.3 %
201148.24 %-52.4 %-35.46 %
201048.37 %-46.12 %-24.08 %
200948.37 %-80.19 %-90.82 %
200848.37 %-207.45 %-286.17 %
200748.37 %-351.06 %-312.77 %
200648.37 %-647.62 %-661.9 %
200548.37 %0 %0 %
200429.03 %-83.87 %-354.84 %

Avacta Group Stock Sales Revenue, EBIT, Earnings per Share

The Avacta Group earnings per share therefore indicates how much revenue Avacta Group has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Avacta Group earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Avacta Group's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Avacta Group’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Avacta Group's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Avacta Group Revenue, EBIT and net profit per share

DateAvacta Group Sales per ShareAvacta Group EBIT per shareAvacta Group Earnings per Share
2026e0.09 undefined0 undefined-0.08 undefined
2025e0.08 undefined0 undefined-0.1 undefined
2024e0.07 undefined0 undefined-0.1 undefined
20230.09 undefined-0.1 undefined-0.09 undefined
20220.04 undefined-0.1 undefined-0.14 undefined
20210.01 undefined-0.12 undefined-0.11 undefined
20200.01 undefined-0.08 undefined-0.08 undefined
20190.05 undefined-0.15 undefined-0.13 undefined
20180.04 undefined-0.1 undefined-0.09 undefined
20170.04 undefined-0.16 undefined-0.13 undefined
20160.04 undefined-0.12 undefined-0.09 undefined
20150.03 undefined-0.08 undefined-0.07 undefined
20140.04 undefined-0.06 undefined-0.2 undefined
20130.08 undefined-0.04 undefined-0.04 undefined
20120.09 undefined-0.06 undefined-0.05 undefined
20110.13 undefined-0.07 undefined-0.04 undefined
20100.16 undefined-0.07 undefined-0.04 undefined
20090.16 undefined-0.13 undefined-0.15 undefined
20080.1 undefined-0.21 undefined-0.28 undefined
20070.06 undefined-0.21 undefined-0.18 undefined
20060.03 undefined-0.2 undefined-0.2 undefined
20050 undefined-0.74 undefined-0.58 undefined
20041.72 undefined-1.44 undefined-6.11 undefined

Avacta Group business model

Avacta Group PLC is a British company specializing in the development of innovative solutions for biotechnology and diagnostics. It was founded in 2004 by Eliot Forster and is headquartered in Wetherby, West Yorkshire. Avacta's history began with the development of Affimer technology, which offers an alternative to conventional antibodies. Affimers are synthetic peptides with high binding affinity to biological molecules, making them important tools for biomedical research and diagnostic applications. The company had limited resources in its early years, and it took several years to complete the development of Affimer technology. In recent years, Avacta has expanded its business model by offering licensed services to pharmaceutical companies. The company provides innovative screening methods and drug discovery tools based on Affimer technology. Avacta has partnerships with major companies such as LG Chem, Moderna, and Wockhardt. The partnership with LG Chem aims to use the platform technology for the development of Covid-19 therapeutics, while the collaboration with Wockhardt focuses on the creation of diagnostic kits and test systems. Avacta's main business areas are biotechnology and diagnostics. The biotechnology division offers screening services for pharmaceutical companies, with a focus on developing higher quality and more efficient antibodies using Affimers, which potentially provide better screening results than traditional antibodies. In the field of diagnostics, the company is working on the development of diagnostic test systems for disease diagnosis. Avacta has started developing diagnostic test kits for Covid-19 that can be used in a laboratory or at home. The company also has a partnership with Adeptrix, a diagnostic tool manufacturing company. Another important area of Avacta is therapeutic applications. Avacta's Affimer technology has already led to new clinical approaches in the development of cancer therapies. Avacta also has a pipeline program of Affimer therapeutics targeting various diseases, from cancer to inflammatory and neurodegenerative diseases. Avacta's products include licensed services for pharmaceutical companies, research kits for Affimer technology, and its own portfolio of Affimer products for various applications in research and diagnostics. The products are exported worldwide, and the company has offices in the United States and South Korea. Overall, Avacta Group PLC has become a major player in the biotechnology and diagnostics industry by expanding its Affimer technology to various applications. Partnerships with major pharmaceutical companies and the development of diagnostic test systems for Covid-19 have brought the company into the public eye and contribute to strengthening its position as a leading provider of Affimer technology in the industry. Avacta Group is one of the most popular companies on Eulerpool.com.

Avacta Group SWOT Analysis

Strengths

Avacta Group PLC has several strengths that contribute to its overall success and competitive advantage. These include:

  • Strong intellectual property portfolio: Avacta Group PLC holds a substantial number of patents and proprietary technologies, allowing them to protect their innovations and maintain a unique market position.
  • Diverse product portfolio: The company offers a wide range of products and services across multiple application areas, enabling them to serve various customer needs and cater to different industries.
  • Expertise in biotechnology: Avacta Group PLC has a team of highly skilled scientists and researchers who possess extensive knowledge in the field of biotechnology, allowing them to develop innovative and high-quality solutions.

Weaknesses

Avacta Group PLC also faces certain weaknesses, which may hinder its growth and performance. These include:

  • Reliance on key customers: The company has a significant dependence on a few major customers for a substantial portion of its revenue. This reliance exposes Avacta Group PLC to the risk of losing key accounts and experiencing financial instability.
  • Limited market presence: Despite its strong offerings, Avacta Group PLC has a relatively smaller market share compared to some of its competitors. This limited market presence may restrict their ability to reach a broader customer base and maximize growth opportunities.
  • Capital constraints: Avacta Group PLC faces capital constraints, which may limit its ability to invest in research and development, expand its operations, or pursue strategic acquisitions. This can restrict their growth potential and hinder their ability to stay competitive.

Opportunities

Avacta Group PLC has several opportunities that can be leveraged to its advantage in the market. These include:

  • Emerging markets: Expanding into emerging markets presents significant growth prospects for Avacta Group PLC. These markets can provide new customer segments, untapped revenue streams, and potential partnerships with local players.
  • Advancements in biotechnology: The continuous advancements in biotechnology present opportunities for Avacta Group PLC to develop and commercialize new products and services. These innovations can help address evolving customer needs and stay ahead of the competition.
  • Strategic collaborations: Collaborating with key industry players or forming strategic partnerships can provide Avacta Group PLC with access to new technologies, distribution channels, and a broader customer base. This can accelerate their market penetration and enhance their competitive position.

Threats

Avacta Group PLC faces certain threats that can negatively impact its business operations and market position. These include:

  • Intense competition: The biotechnology industry is highly competitive, with numerous companies competing for market share. Avacta Group PLC faces the risk of losing customers to competitors who offer similar or better products at competitive prices.
  • Regulatory challenges: The biotechnology sector is subject to strict regulations and compliance requirements. Changes in regulations or failure to meet these requirements may lead to delays in product approvals, increased costs, or legal issues for Avacta Group PLC.
  • Economic downturns: Economic downturns or financial uncertainties can impact customer spending in the biotechnology sector. Avacta Group PLC may experience decreased demand for its products and services during economic downturns, affecting its revenue and profitability.

Avacta Group Revenue by Segment

  • 3 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Avacta Group Revenue by Segment

Segmente2021
Computex96.94 M USD
Consolidated20.05 M USD
Kandy20.05 M USD
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Avacta Group Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Avacta Group historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Avacta Group shares outstanding

The number of shares was Avacta Group in 2024 — This indicates how many shares 272.684 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Avacta Group earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Avacta Group's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Avacta Group’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Avacta Group's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Avacta Group stock splits

In Avacta Group's history, there have been no stock splits.
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Avacta Group.

Avacta Group latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
12/31/2022-0.05 -0.08  (-48.16 %)2022 Q4
1

Avacta Group shareholders

%
Name
Stocks
Change
Date
3.20825 % Lombard Odier Asset Management (Europe) Ltd11,848,38911,848,3894/29/2024
2.74143 % Baillie Gifford & Co.10,124,37106/22/2023
2.16428 % Hughes (Robert Anthony)7,992,901801,3603/19/2024
1.44438 % Kamani (Umar Mahmud)5,334,240534,2403/19/2024
1.22906 % AXA Investment Managers UK Ltd.4,539,027-30,4438/31/2024
1.16433 % Unicorn Asset Management Ltd.4,300,00003/19/2024
0.83414 % Premier Asset Management Ltd3,080,561806,6343/21/2024
0.75338 % Avacta Group Plc Employees' Share Trust2,782,30607/15/2024
0.65158 % Muir (Andrew Hugh John)2,406,3321,268,1133/20/2024
0.52595 % Robbins (Sheldon Bryan)1,942,40103/20/2024
1
2
3
4
5
...
10

Avacta Group Executives and Management Board

Dr. Alastair Smith

Avacta Group Chief Executive Officer, Executive Director
Compensation 427,000

Mr. Tony Gardiner

(50)
Avacta Group Chief Financial Officer, Company Secretary, Executive Director (since 2016)
Compensation 262,000

Dr. Eliot Forster

(55)
Avacta Group Non-Executive Independent Chairman of the Board
Compensation 100,000

Dr. Mark Goldberg

(68)
Avacta Group Non-Executive Independent Director
Compensation 45,000

Mr. Paul Fry

Avacta Group Non-Executive Independent Director
Compensation 40,000
1
2

Avacta Group Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
JSR Stock
JSR
SupplierCustomer0,48-0,390,110,58-0,25-0,18
Danaher Stock
Danaher
SupplierCustomer0,45-0,68-0,340,44-0,25-0,35
ADC Therapeutics Stock
ADC Therapeutics
SupplierCustomer0,33-0,57-0,650,430,450,17
Moderna Stock
Moderna
SupplierCustomer0,02-0,56-0,150,570,21-0,18
Abingdon Health Stock
Abingdon Health
SupplierCustomer-0,21-0,440,040,620,76
1

Most common questions regarding Avacta Group

What values and corporate philosophy does Avacta Group represent?

Avacta Group PLC represents a strong commitment to innovation, excellence, and high-quality solutions in the healthcare sector. By focusing on developing and commercializing novel biotherapeutics and diagnostics, Avacta Group aims to improve patient outcomes and transform the way diseases are diagnosed and treated. Their corporate philosophy is centered around collaboration, strategic partnerships, and delivering value for all stakeholders. Avacta Group PLC constantly strives to stay at the forefront of cutting-edge technologies and leverage their expertise to address significant medical challenges. With a relentless drive for scientific advancements, Avacta Group PLC aims to revolutionize healthcare by providing innovative and effective solutions to improve global health.

In which countries and regions is Avacta Group primarily present?

Avacta Group PLC is primarily present in the United Kingdom (UK).

What significant milestones has the company Avacta Group achieved?

Avacta Group PLC, a leading biotechnology company, has achieved several significant milestones. Firstly, they successfully developed a novel Affimer® technology, revolutionizing the field of protein engineering. Avacta also secured multiple key partnerships with industry leaders, such as LG Chem Life Sciences and Tufts University, to accelerate commercialization. Furthermore, the company obtained regulatory approval for their rapid COVID-19 antigen test, demonstrating their commitment to public health. Avacta received the CE Mark certification for its clinically validated SARS-CoV-2 rapid antigen test, facilitating global distribution. Such accomplishments highlight Avacta Group PLC's dedication to innovation, collaborations, and advancing healthcare solutions.

What is the history and background of the company Avacta Group?

Avacta Group PLC is a leading biotechnology company, specializing in the development and commercialization of cutting-edge technologies. With a rich history and strong background, Avacta has been at the forefront of innovative solutions since its inception. Established in 2004 and headquartered in the United Kingdom, Avacta has built a solid reputation for its expertise in Affimer® technology, an alternative to antibodies. Avacta's extensive portfolio includes products and services for various sectors, including diagnostics, therapeutics, and research. With a commitment to revolutionizing the healthcare industry, Avacta Group PLC continues to drive advancements in precision medicine and deliver transformative solutions for global health challenges.

Who are the main competitors of Avacta Group in the market?

The main competitors of Avacta Group PLC in the market are companies like Abcam, Bio-Rad Laboratories, and Thermo Fisher Scientific.

In which industries is Avacta Group primarily active?

Avacta Group PLC is primarily active in the biotechnology and healthcare industries.

What is the business model of Avacta Group?

The business model of Avacta Group PLC revolves around the development and commercialization of innovative life science tools and technologies. Avacta Group specializes in the development of Affimer® platform, a versatile technology with multiple applications in diagnostics, therapeutics, and research. The company aims to leverage its proprietary technology to provide solutions for various sectors including biotechnology, healthcare, and pharmaceuticals. Avacta Group focuses on collaborations and partnerships to accelerate commercialization and maximize the potential of its Affimer® platform. Through its dedication to innovation and strategic partnerships, Avacta Group aims to drive growth and create value for shareholders and stakeholders.

What is the P/E ratio of Avacta Group 2025?

The Avacta Group P/E ratio is -3.86.

What is the P/S ratio of Avacta Group 2025?

The Avacta Group P/S ratio is 4.91.

What is the Quality Investing of Avacta Group?

The Quality Investing for Avacta Group is 6/10.

What is the revenue of Avacta Group 2025?

The expected Avacta Group revenue is 27.76 M GBP.

How high is the profit of Avacta Group 2025?

The expected Avacta Group profit is -35.28 M GBP.

What is the business model of Avacta Group

The Avacta Group PLC is a biotechnology and diagnostics company specialized in the development and commercialization of technologies and applications in the life sciences and healthcare sectors. The company offers innovative products and services for disease detection and treatment, as well as pharmaceutical research. It operates in two business areas: "Life Sciences" and "Animal Health." The "Life Sciences" business focuses on providing tools and services for drug discovery and therapy development, particularly in the field of recombinant affinity reagents. The "Animal Health" business concentrates on developing diagnostic tests for various animals, including dogs, cats, horses, and cattle. Avacta's products include affinity reagents, reactive surfaces, assays, and devices for both research and clinical use. The company has also developed a proprietary immunoclonal format called Affimer, which is an alternative to antibodies for biomarker detection and quantification. Avacta offers custom services for Affimer applications. Established in 2004, Avacta Group is listed on the London Stock Exchange and headquartered in Wetherby, Yorkshire, with additional offices in Cambridge and San Diego. The company collaborates with customers and partners in the biotechnology, pharmaceutical, and diagnostics sectors to develop innovative products. It aims to expand its leadership position in biotechnology and diagnostics by continually enhancing its product and service pipeline.Most relevantly, Avacta Group provides a wide range of products and services in the life sciences and animal health sectors, employing advanced technologies for disease detection and treatment. It is committed to promoting biotechnological research and development and delivering innovative products for clinical application.

What is the Avacta Group dividend?

Avacta Group pays a dividend of 0 GBP distributed over payouts per year.

How often does Avacta Group pay dividends?

The dividend cannot currently be calculated for Avacta Group or the company does not pay out a dividend.

What is the Avacta Group ISIN?

The ISIN of Avacta Group is GB00BYYW9G87.

What is the Avacta Group WKN?

The WKN of Avacta Group is A2ADP0.

What is the Avacta Group ticker?

The ticker of Avacta Group is AVCT.L.

How much dividend does Avacta Group pay?

Over the past 12 months, Avacta Group paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Avacta Group is expected to pay a dividend of 0 GBP.

What is the dividend yield of Avacta Group?

The current dividend yield of Avacta Group is .

When does Avacta Group pay dividends?

Avacta Group pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Avacta Group?

Avacta Group paid dividends every year for the past 0 years.

What is the dividend of Avacta Group?

For the upcoming 12 months, dividends amounting to 0 GBP are expected. This corresponds to a dividend yield of 0 %.

In which sector is Avacta Group located?

Avacta Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Avacta Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Avacta Group from 1/1/2025 amounting to 0 GBP, you needed to have the stock in your portfolio before the ex-date on 1/1/2025.

When did Avacta Group pay the last dividend?

The last dividend was paid out on 1/1/2025.

What was the dividend of Avacta Group in the year 2024?

In the year 2024, Avacta Group distributed 0 GBP as dividends.

In which currency does Avacta Group pay out the dividend?

The dividends of Avacta Group are distributed in GBP.

All fundamentals about Avacta Group

Our stock analysis for Avacta Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Avacta Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.